0

Global Bladder Cancer Therapeutics Market 2017-2021

  • Published: May 2017
  • Pages: 70
  • SKU: IRTNTR13172
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research study identifies Bristol-Myers Squibb, Eli Lilly, F. Hoffman-La Roche, and Pfizer as the leading players in the global bladder cancer therapeutics market. A comprehensive analysis of this market is also presented by therapy (intravesical therapy, chemotherapy, and preservation therapy, and others) and by geography (the Americas, APAC, and EMEA).

Global bladder cancer therapeutics market forecasts

According to bladder cancer therapeutics industry insights, the global bladder cancer therapeutics market will grow at a CAGR of close to 5% during the forecast period. The availability of targeted therapy will be one of the major factors driving the growth prospects for the market until the end of 2021. The advancements in drug targeting techniques have enabled doctors to administer drugs directly into the bladder having tumors. This, in turn, will help in avoiding the side effects of these drugs on healthy cells. With a better understanding of tumor, immunology scientists can also now develop new drugs targeted at cancer cells. TECENTRIQ and OPDIVO are the PD-L1 inhibitors recently approved by the US FDA for the treatment of urothelial carcinoma.

One of the effective procedures for the diagnosis of bladder cancer, cystoscopy, involves the use of a long thin tube called cystoscope. This helps the urologist to extract a small piece of the abnormal tissue and send it to the pathologists for examination. With the emergence of effective diagnostic tools such as the flexible cystoscope, urologists will prefer cystoscopy since it can be easily performed in the outpatient department. This emergence of effective diagnostic tools will be one of the major trends that will gain traction in the bladder cancer therapeutics market during the next four years.

Competitive landscape and key vendors

The bladder cancer therapeutics market consists of a few vendors who concentrate on improving their profit margins through direct sales and through distributor channels. The competition among the players in this market space is mainly based on factors including emerging indications or applications and collaborations. To improve their market positions, the vendors are increasingly focusing on the development of new products and gaining approvals. To develop new products, a few vendors are also concentrating on partnering with other market players.  

Key vendors in this market are 

  • Bristol-Myers Squibb
  • Eli Lilly
  • F. Hoffman-La Roche
  • Pfizer

Other prominent vendors in the market include Accord Healthcare, AstraZeneca, Bedford Lab, Merck, and Sanofi.

Segmentation by therapy and analysis of the bladder cancer therapeutics market

  • Intravesical therapy
  • Chemotherapy
  • Preservation therapy

Chemotherapy is mainly used for the treatment of invasive cancer and relieve bladder cancer symptoms by declining the rate at which cancer spreads. This market study estimates that the chemotherapy segment that includes neoadjuvant chemotherapy and adjuvant chemotherapy accounted for the major shares of the bladder cancer therapeutics market during 2016. This is mainly due to the increase in incidences of bladder cancer and the growing adoption of chemotherapy in the developing countries.

Segmentation by geography and analysis of the bladder cancer therapeutics market

  • Americas
  • APAC
  • EMEA

Based on the bladder cancer therapeutics market growth analysis, the Americas will be the major revenue contributor to the market during 2016. Though the bladder cancer therapeutics market in the Americas will grow at a lesser rate than the other regions, this region will continue its market dominance throughout the predicted period due to factors such as the increasing focus of vendors to develop targeted therapies and the presence of major vendors such as Pfizer and Merck.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the global bladder cancer therapeutics market?
  • What are the key market trends impacting the growth of the global bladder cancer therapeutics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global bladder cancer therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global bladder cancer therapeutics market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global bladder cancer therapeutics market?

Technavio also offers customization on reports based on specific client requirement.

 

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline
  • Bladder
  • Bladder cancer
  • Currently approved therapeutic regimen
  • Stages of bladder cancer

PART 05: Key clinical trials

PART 06: Market landscape

  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by therapy

  • Intravesical therapy
  • Chemotherapy
  • Preservation therapy
  • Others

PART 08: Geographical segmentation

  • Bladder cancer therapeutics market in Americas
  • Bladder cancer therapeutics market in EMEA
  • Bladder cancer therapeutics market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Growing influence of targeted biologics
  • Advent of novel pipeline
  • Emergence of effective diagnostic tools

PART 12: Vendor landscape

  • Competitive landscape

PART 13: Key vendor analysis

  • Bristol-Myers Squibb
  • Eli Lilly
  • F. Hoffman-La Roche
  • Pfizer
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>